Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple system atrophy

J Kulczycki1

  • 1Department of Neurology, Institute of Psychiatry and Neurology, Warszawa.

Folia Neuropathologica
|January 1, 1997
PubMed
Summary

Multiple system atrophy (MSA) is a fatal neurodegenerative disease. Its hallmark is glial cytoplasmic inclusions in the brain, distinguishing it from its individual components.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.

European journal of neurology·2007
Same author

CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Neurology·2006
Same author

[Considerations of biopsy in neurological diagnosis].

Neurologia i neurochirurgia polska·2002
Same author

Epidemiological studies on Creutzfeldt-Jakob disease in Poland.

Folia neuropathologica·2002
Same author

Amyotrophic form of Creutzfeldt-Jakob disease with rapid course in 82-year-old man.

Folia neuropathologica·2001
Same author

Report on the first polish case of the Gerstmann-Sträussler-Scheinker syndrome.

Folia neuropathologica·2001

Area of Science:

  • Neuroscience
  • Neuropathology

Background:

  • Multiple system atrophy (MSA) is a progressive central nervous system disorder.
  • MSA encompasses nigrostriatal degeneration (NSD), olivopontocerebellar atrophy (OPCA), and autonomic dysfunction (Shy-Drager syndrome, SDS).
  • MSA has a more rapid clinical progression and poorer prognosis than its individual components.

Purpose of the Study:

  • To describe the key neuropathological findings in Multiple System Atrophy.
  • To highlight the significance of glial cytoplasmic inclusions in MSA diagnosis.

Main Methods:

  • Review of neuropathological findings in Multiple System Atrophy cases.
  • Histopathological examination focusing on glial cell inclusions.

Main Results:

  • A common neuropathological finding in MSA is the presence of argyrophilic inclusions.
  • These inclusions are primarily found in the cytoplasm of glial cells, particularly oligodendrocytes.
  • Inclusions are located in brain structures exhibiting the most pronounced atrophic changes.

Conclusions:

  • Glial cytoplasmic inclusions are a significant neuropathological hallmark of MSA.
  • The presence of these inclusions aids in the diagnosis of MSA.
  • Understanding these findings is crucial for differentiating MSA from its constituent syndromes.

Related Experiment Videos